Many R.Ph.s see Drug Topics as a trusted friend
Here are some of the nice things they had to say:
"Since joining ASHP, I have enjoyed and appreciated the bond of friendship and professional relationship that has developed between the staff of Drug Topics and the ASHP 'family.' You cover the issues of health-system pharmacy in a comprehensive fashion. You dig deep where required. Judy Chi and Tony Vecchione are always active participants in our press briefings, and they are never shy about asking us the tough questions. Thanks for being part of our profession in a sustained and committed fashion."
John Rector, senior VP and general counsel of NCPA, commented, "Even in the years 1971 to 1977 when I was a chief counsel for the Senate Judiciary Committee, my staff of lawyers and investigators and I used Drug Topics in a variety of ways: to understand the sector and the issues confronting the practice of pharmacy, especially the local privately owned business and for ideas for legislation or leads for hearing subjects and/or witnesses. Throughout my years as general counsel and senior VP with the National Association of Retail Druggists [NARD] and now NCPA, I have found Drug Topics to be a timely and reliable source of essential information. Access on-line to the publication and your frequent updates have only served to enhance its value."
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.